血液动力学监测系统市场规模、份额、成长分析：按产品、类型、最终用户、地区 - 产业预测，2024-2031

预计2022年全球血流动力学监测系统市场规模将达11亿美元，从2023年的11.6亿美元增加至2031年的19.2亿美元，预计复合年增长率为6.4%。

由于几个关键因素（主要是高科技创新），血液动力学监测系统市场正在强劲成长。低血压预测指数 (HPI) 软体的整合等进步极大地提高了这些医疗设备的准确性和功能。同时，针对血流动力学监测系统的研究的增加正在刺激其在临床实践中的发展和采用。全球心血管疾病和糖尿病发生率的增加增加了对先进监测解决方案的需求。此外，老年人口的增加和外科手术比例的增加正在推动市场扩张。此外，电子机械系统 (MEMS) 的采用凸显了我们对最尖端科技的承诺，以提供更好的患者照护。旨在加强医疗基础设施的政府措施也是支持市场成长的关键因素。随着血流动力学监测系统不断进步并在重症加护领域获得关注，在技术创新、医疗保健需求和策略意识倡议的推动下，市场成长轨迹可能会持续下去。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 技术分析
• 价值链分析
• 市场生态系统
• 监管环境
• 创新矩阵
• 主要投资分析
• 关键成功因素
• 市场魅力指数
• 竞争程度

血流动力学监测系统市场：副产品

• 市场概况
• 监视器
• 消耗品
• 其他的

血流动力学监测系统市场：按类型

• 市场概况
• 侵入性的
• 非侵入性
• 其他的

血流动力学监测系统市场：依最终用户分类

• 市场概况
• 医院
• 诊所
• 门诊治疗中心
• 居家医疗
• 其他的

按地区分類的血流动力学监测系统市场规模

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Edwards Lifesciences Corporation（United States）
• ICU Medical, Inc.（United States）
• Baxter International Inc.（United States）
• LiDCO Group Plc（United Kingdom）
• Cheetah Medical（United States）
• Deltex Medical Group plc（United Kingdom）
• GE Healthcare（United States）
• Philips Healthcare（Netherlands）
• Nihon Kohden Corporation（Japan）
• Siemens Healthineers AG（Germany）
• CardioDynamics International Corporation（United States）
• Osypka Medical GmbH（Germany）
• Schwarzer Cardiotek GmbH（Germany）
• Uscom Limited（Australia）
• Getinge AB（Sweden）
• Nonin Medical, Inc.（United States）
• Tensys Medical, Inc.（United States）
• CareTaker Medical, LLC（United States）
• CNSystems Medizintechnik AG（Austria）
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.（China）

Global Hemodynamic Monitoring Systems Market size was valued at USD 1.10 billion in 2022 and is poised to grow from USD 1.16 billion in 2023 to USD 1.92 billion by 2031, growing at a CAGR of 6.4% in the forecast period (2024-2031).

The hemodynamic monitoring systems market is experiencing robust growth driven by several key factors, primarily advanced technological innovations. These advancements, such as the integration of hypotension prediction index (HPI) software, have significantly improved the accuracy and capabilities of these medical devices. Concurrently, increased research dedicated to hemodynamic monitoring systems is fueling their evolution and adoption across clinical settings. Demand is further bolstered by rising global incidences of cardiovascular diseases and diabetes, prompting a surge in the need for sophisticated monitoring solutions. Additionally, a growing elderly population and escalating rates of surgical procedures are pivotal in propelling market expansion. Industry efforts to raise awareness about the benefits of these systems among enterprises are expanding their market reach, while the adoption of microelectromechanical systems (MEMS) underscores a commitment to cutting-edge technologies for better patient care. Government initiatives aimed at strengthening healthcare infrastructure are also pivotal in supporting market growth. As hemodynamic monitoring systems continue to advance and gain prominence in critical care, their trajectory of market growth is poised to persist, driven by technological innovation, healthcare demands, and strategic awareness initiatives.

Top-down and bottom-up approaches were used to estimate and validate the size of the Hemodynamic Monitoring Systems Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Hemodynamic Monitoring Systems Market Segmental Analysis

The global hemodynamic monitoring systems market is segmented on the basis of product, type, end user, and region. Based on product, the market is segmented into monitors and disposables. Based on type, the market is segmented into Invasive, Non-invasive and Others. Based on end user, the market is segmented into Hospitals, Clinics, Ambulatory care centers, Home Care Settings and Others. Based on region, the market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East & Africa.

Drivers of the Hemodynamic Monitoring Systems Market

Advancements in hemodynamic monitoring systems have continually evolved, ushering in significant technological progress and the development of increasingly sophisticated, precise, and non-invasive monitoring devices. This evolution has profoundly influenced patient outcomes and healthcare efficiency. The introduction of non-invasive hemodynamic monitoring devices, employing sensors on the patient's skin for measuring blood flow and pressure, represents a revolutionary shift in monitoring practices.

Restraints in the Hemodynamic Monitoring Systems Market

Noninvasive hemodynamic monitoring systems represent a significant advancement in medical diagnostics, offering painless procedures and reducing the risk of blood-borne infections in patients. Their simplicity and accessibility make them suitable for use by nurses without specialized medical training, facilitating simultaneous monitoring of multiple patients' hemodynamic states. This streamlined approach not only simplifies monitoring but also lowers staffing and treatment costs. These inherent benefits underscore the pivotal role of noninvasive hemodynamic monitoring systems in modern healthcare, driving their widespread adoption and promising market growth in the coming years.

Market Trends of the Hemodynamic Monitoring Systems Market

The hemodynamic monitoring systems market is experiencing robust growth driven by multiple factors. These include the rising population of critically ill elderly individuals, the high incidence of heart diseases and diabetes, increasing demand for non-invasive and home-based monitoring solutions, and a growing number of hypertensive patients. The aging demographic, prone to various health challenges and critical illnesses, underscores the escalating need for advanced monitoring technologies. Globally prevalent heart diseases and diabetes further amplify the demand for such monitoring systems.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Market Attractive Index
• Degree of Competition

Global Hemodynamic Monitoring Systems Market by Product

• Market Overview
• Monitors
• Disposables
• Others

Global Hemodynamic Monitoring Systems Market by Type

• Market Overview
• Invasive
• Non-invasive
• Others

Global Hemodynamic Monitoring Systems Market by End User

• Market Overview
• Hospitals
• Clinics
• Ambulatory care centres
• Home care settings
• Others

Global Hemodynamic Monitoring Systems Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Edwards Lifesciences Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICU Medical, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LiDCO Group Plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cheetah Medical (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Deltex Medical Group plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CardioDynamics International Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Osypka Medical GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schwarzer Cardiotek GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Uscom Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nonin Medical, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tensys Medical, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CareTaker Medical, LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CNSystems Medizintechnik AG (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments